| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1001793951 |
| P356 | DOI | 10.1038/NPP.2013.57 |
| P8608 | Fatcat ID | release_p5liqhcxtvcupk4vfgiruejwsm |
| P932 | PMC publication ID | 3682152 |
| P698 | PubMed publication ID | 23446451 |
| P5875 | ResearchGate publication ID | 235749924 |
| P50 | author | Andrew Harkin | Q43111042 |
| Kumlesh K. Dev | Q50421348 | ||
| Terri A Levine | Q58888171 | ||
| P2093 | author name string | Marika V Doucet | |
| P2860 | cites work | Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders | Q24632936 |
| Nitric oxide synthases: structure, function and inhibition | Q28207668 | ||
| Behavioral despair in mice: a primary screening test for antidepressants | Q28258027 | ||
| Forced swimming test in mice: a review of antidepressant activity | Q28299108 | ||
| Physical interaction between the serotonin transporter and neuronal nitric oxide synthase underlies reciprocal modulation of their activity | Q28593956 | ||
| mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists | Q29618120 | ||
| NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses | Q30471587 | ||
| Formation of nNOS/PSD-95 PDZ dimer requires a preformed beta-finger structure from the nNOS PDZ domain. | Q30616861 | ||
| Behavioral effects of ketamine and toxic interactions with psychostimulants | Q33236744 | ||
| Nitric oxide and major depression | Q34165714 | ||
| In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice | Q34292427 | ||
| Nitric oxide involvement in the antidepressant-like effects of acute lithium administration in the mouse forced swimming test. | Q34668494 | ||
| Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure | Q34744471 | ||
| Signaling pathways underlying the rapid antidepressant actions of ketamine | Q35375293 | ||
| A single subanesthetic dose of ketamine relieves depression-like behaviors induced by neuropathic pain in rats | Q35569752 | ||
| The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice | Q36125191 | ||
| The physiology and pathophysiology of nitric oxide in the brain. | Q36237916 | ||
| The ascent of mouse: advances in modelling human depression and anxiety | Q36247092 | ||
| Ketamine as a novel antidepressant: from synapse to behavior | Q36905864 | ||
| Glutamate-based antidepressants: 20 years on. | Q37616806 | ||
| Nitric Oxide Synthase Inhibitors as Antidepressants | Q37709458 | ||
| The PSD-95/nNOS complex: new drugs for depression? | Q37963635 | ||
| CD-1 and Balb/cJ mice do not show enduring antidepressant-like effects of ketamine in tests of acute antidepressant efficacy | Q39272309 | ||
| Behavioural despair in rats: A new model sensitive to antidepressant treatments | Q40134604 | ||
| PSD-95 assembles a ternary complex with the N-methyl-D-aspartic acid receptor and a bivalent neuronal NO synthase PDZ domain | Q40928878 | ||
| Selective inhibitors of neuronal nitric oxide synthase--is no NOS really good NOS for the nervous system? | Q41534673 | ||
| Disruption of nNOS-PSD95 protein-protein interaction inhibits acute thermal hyperalgesia and chronic mechanical allodynia in rodents | Q41884437 | ||
| Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95. | Q42794015 | ||
| Involvement of serotonin receptor subtypes in the antidepressant-like effect of TRIM in the rat forced swimming test | Q43156061 | ||
| A role for serotonin in the antidepressant activity of NG-Nitro-L-arginine, in the rat forced swimming test. | Q43234169 | ||
| Effects of L-arginine on 7-nitroindazole-induced reference and working memory performance of rats | Q43279443 | ||
| Reduction in preference for saccharin by repeated unpredictable stress in mice and its prevention by imipramine | Q44048454 | ||
| Antidepressant- and anxiolytic-like effects of selective neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole in mice | Q44366974 | ||
| Serotonergic mediation of the antidepressant-like effects of nitric oxide synthase inhibitors | Q44385244 | ||
| Involvement of NMDA receptors and L-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice. | Q44567452 | ||
| Nitric oxide synthase inhibitors augment the effects of serotonin re-uptake inhibitors in the forced swimming test | Q44910806 | ||
| Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats. | Q46014089 | ||
| Effects of neuronal and inducible NOS inhibitor 1-[2-(trifluoromethyl) phenyl] imidazole (TRIM) in unpredictable chronic mild stress procedure in mice | Q46235950 | ||
| Lack of persistent effects of ketamine in rodent models of depression | Q46610466 | ||
| Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors | Q48099473 | ||
| Effects of nitric oxide synthase inhibitors 1-(2-trifluoromethylphenyl)--imidazole (TRIM) and 7-nitroindazole (7-NI) on learning and memory in mice | Q48137438 | ||
| Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression | Q48255836 | ||
| New and potent inhibitors of nitric oxide synthase reduce motor activity in mice | Q48618285 | ||
| Intra- and interstrain differences in models of "behavioral despair". | Q48717342 | ||
| 7-Nitroindazole, a neuronal nitric oxide synthase inhibitor, impairs passive-avoidance and elevated plus-maze memory performance in rats. | Q50895784 | ||
| Nitric oxide synthase inhibitors impair reference memory formation in a radial arm maze task in rats. | Q52038363 | ||
| 7-Nitro indazole, a selective neuronal nitric oxide synthase inhibitor in vivo, impairs spatial learning in the rat. | Q52049689 | ||
| Neuronal nitric oxide synthase contributes to chronic stress-induced depression by suppressing hippocampal neurogenesis. | Q52582093 | ||
| Antidepressant-like actions of an AMPA receptor potentiator (LY392098). | Q53972514 | ||
| Nitric oxide synthases: structure, function and inhibition | Q55951119 | ||
| The tail suspension test: a new method for screening antidepressants in mice | Q69947780 | ||
| Evidence for dual effects of nitric oxide in the forced swimming test and in the tail suspension test in mice | Q73298429 | ||
| Nitric oxide synthase inhibitors have antidepressant-like properties in mice. 1. Acute treatments are active in the forced swim test | Q77965235 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1575-1584 | |
| P577 | publication date | 2013-02-27 | |
| P1433 | published in | Neuropsychopharmacology | Q2261280 |
| P1476 | title | Small-molecule inhibitors at the PSD-95/nNOS interface have antidepressant-like properties in mice | |
| P478 | volume | 38 |
| Q40733593 | Biochemical investigations of the mechanism of action of small molecules ZL006 and IC87201 as potential inhibitors of the nNOS-PDZ/PSD-95-PDZ interactions |
| Q33635613 | Delineation of molecular pathway activities of the chronic antidepressant treatment response suggests important roles for glutamatergic and ubiquitin-proteasome systems |
| Q38245421 | Dissecting the role of polarity regulators in cancer through the use of mouse models. |
| Q35162554 | Effect of the fragrance inhalation of essential oil from Asarum heterotropoides on depression-like behaviors in mice. |
| Q37699516 | Efficient Binding of the NOS1AP C-Terminus to the nNOS PDZ Pocket Requires the Concerted Action of the PDZ Ligand Motif, the Internal ExF Site and Structural Integrity of an Independent Element |
| Q40569105 | Fluorination Effects on NOS Inhibitory Activity of Pyrazoles Related to Curcumin. |
| Q37559823 | Ketamine as antidepressant? Current state and future perspectives |
| Q36010727 | Mas-Related Gene (Mrg) C Activation Attenuates Bone Cancer Pain via Modulating Gi and NR2B |
| Q35586357 | NMDA receptor subunits and associated signaling molecules mediating antidepressant-related effects of NMDA-GluN2B antagonism |
| Q92102996 | PDZ Domains as Drug Targets |
| Q58708002 | PSD-95-nNOS Coupling Regulates Contextual Fear Extinction in the Dorsal CA3 |
| Q58783067 | PSD95 and nNOS interaction as a novel molecular target to modulate conditioned fear: relevance to PTSD |
| Q37330439 | Purine and pyrimidine metabolism: Convergent evidence on chronic antidepressant treatment response in mice and humans |
| Q42052984 | Regional Specific Modulation of Stress-Induced Neuronal Activation Associated with the PSD95/NOS Interaction Inhibitor ZL006 in the Wistar Kyoto Rat. |
| Q35962657 | Small molecule inhibitors of PSD95-nNOS protein-protein interactions as novel analgesics |
| Q48267280 | Small molecule inhibitors of PSD95-nNOS protein-protein interactions suppress formalin-evoked Fos protein expression and nociceptive behavior in rats |
| Q36730701 | Source memory in rats is impaired by an NMDA receptor antagonist but not by PSD95-nNOS protein-protein interaction inhibitors |
| Q38189780 | The emerging role of dopamine-glutamate interaction and of the postsynaptic density in bipolar disorder pathophysiology: Implications for treatment |
| Q59137339 | The social defeat/overcrowding murine psychosocial stress model results in a pharmacologically reversible body weight gain but not depression - related behaviours |
| Q47112810 | UV irradiation to mouse skin decreases hippocampal neurogenesis and synaptic protein expression via HPA axis activation |
| Q48179080 | Unexpected Heterodivalent Recruitment of NOS1AP to nNOS Reveals Multiple Sites for Pharmacological Intervention in Neuronal Disease Models. |
| Q38647566 | ZL006, a small molecule inhibitor of PSD-95/nNOS interaction, does not induce antidepressant-like effects in two genetically predisposed rat models of depression and control animals. |
Search more.